Loss-of-function mutations in SUR1 or less commonly, KCNJ11, lead to hyperinsulinism (19), whereas mutations in KCNJ11 that decrease ATP inhibition of KATP cause neonatal permanent neonatal diabetes (20). Here, KCNJ11 is linked to hyperinsulinism.